查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1314884

自我注射药物市场：类型、用途、通路、治疗领域用途- 全球预测 2023-2030

Self-injections Market by Type, Usage, Distribution Channel, Therapeutic Areas Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球自註射药物市场预计到2023年将大幅成长525亿美元，复合年增长率为13.42%，到2030年将达到1,280.4亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球自註射药物市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发地区、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.全球自註射药品市场规模及预测是多少？

2.在预测期内，COVID-19对全球自我注射药物市场的阻碍因素与影响有哪些？

3. 在预测期内，全球自註射药物市场需要投资哪些产品/细分市场/应用/领域？

4.全球自註射药市场的竞争策略为何？

5. 全球自註射药物市场的技术趋势和法律规范是什么？

6.全球自註射药品市场主要供应商的市占率是多少？

7. 哪些型态和策略性措施被认为适合进入全球自註射药物市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病和类风湿性关节炎的快速蔓延
      • 自註射装置技术的进步
      • 生物製剂和生物相似药的药物传输潜力
    • 抑制因素
      • 法规严格，专利审批意识淡薄
    • 机会
      • 开发治疗自体免疫疾病的生物製剂
      • 全球糖尿病发生率上升，医疗费用压力日益增大
    • 任务
      • 更多使用替代运输方式
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章自行注射药品市场：依类型

  • 自动注射器
  • 无针注射器
  • 笔式註射器
  • 穿戴式註射器

第7章用途的自註射药品市场

  • 一次性的
  • 可重复使用的

第8章自註射药品市场：依通路

  • 医院药房
  • 网路药房
  • 私人诊所

第9章依治疗领域分類的自註射药品市场应用

  • 自体免疫疾病
    • AIDS
    • 过敏
    • 癌症
    • 肠躁症
    • 多发性硬化症
    • 银屑病
  • 急诊医学
    • 过敏袜
    • 偏头痛
  • 荷尔蒙替代疗法
    • β干扰素
    • 促红血球生成素
    • 卵泡刺激素
    • 肝素
    • 胰岛素
    • 副甲状腺素
    • 帕金森氏症

第10章美洲自行注射毒品市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第11章亚太自註射药品市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第12章欧洲、中东及非洲自註射药品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第13章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业
    • 新产品发布和功能增强

第14章上市公司名单

第15章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-03050D1B2DB5

The Global Self-injections Market is forecasted to grow significantly, with a projected USD 52.50 billion in 2023 at a CAGR of 13.42% and expected to reach a staggering USD 128.04 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Self-injections Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Self-injections Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Auto-Injectors, Needle-free Injectors, Pen Injectors, and Wearable Injectors. The Pen Injectors commanded largest market share of 34.26% in 2022, followed by Needle-free Injectors.

Based on Usage, market is studied across Disposable and Reusable. The Disposable commanded largest market share of 71.63% in 2022, followed by Reusable.

Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Private Clinics. The Hospital Pharmacies commanded largest market share of 57.34% in 2022, followed by Private Clinics.

Based on Therapeutic Areas Application, market is studied across Autoimmune Diseases, Emergency Drugs, and Hormone Replacement Therapies. The Autoimmune Diseases is further studied across AIDS, Allergies, Cancer, Irritable Bowel Disorders, Multiple Sclerosis, and Psoriasis. The Emergency Drugs is further studied across Anaphylactic Socks and Migraine. The Hormone Replacement Therapies is further studied across Beta-Interferon, Erythropoietin, Follicle Stimulating Hormone, Heparin, Insulin, Parathyroid Hormone, and Parkinson's. The Hormone Replacement Therapies commanded largest market share of 39.12% in 2022, followed by Autoimmune Diseases.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 38.95% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Self-injections Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Self-injections Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Self-injections Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Self-injections Market?

4. What is the competitive strategic window for opportunities in the Global Self-injections Market?

5. What are the technology trends and regulatory frameworks in the Global Self-injections Market?

6. What is the market share of the leading vendors in the Global Self-injections Market?

7. What modes and strategic moves are considered suitable for entering the Global Self-injections Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Self-injections Market, by Type, 2022 vs 2030
  • 4.3. Self-injections Market, by Usage, 2022 vs 2030
  • 4.4. Self-injections Market, by Distribution Channel, 2022 vs 2030
  • 4.5. Self-injections Market, by Therapeutic Areas Application, 2022 vs 2030
  • 4.6. Self-injections Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rapid Prevalence of Chronic Diseases and Rheumatoid Arthritis
      • 5.1.1.2. Technological Advancements in Self-Injection Devices
      • 5.1.1.3. Availability in Drug Delivery for Biological and Biosimilar Drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Strict Regulation for Patent Approval and Lack of Awareness
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of Biologic Drugs to Treat Autoimmune Disease
      • 5.1.3.2. Worldwide Increase in Diabetes and the Growing Pressure on Health Care Costs
    • 5.1.4. Challenges
      • 5.1.4.1. Growing Use of Alternative Delivery Methods
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Self-injections Market, by Type

  • 6.1. Introduction
  • 6.2. Auto-Injectors
  • 6.3. Needle-free Injectors
  • 6.4. Pen Injectors
  • 6.5. Wearable Injectors

7. Self-injections Market, by Usage

  • 7.1. Introduction
  • 7.2. Disposable
  • 7.3. Reusable

8. Self-injections Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Private Clinics

9. Self-injections Market, by Therapeutic Areas Application

  • 9.1. Introduction
  • 9.2. Autoimmune Diseases
    • 9.2.1. AIDS
    • 9.2.2. Allergies
    • 9.2.3. Cancer
    • 9.2.4. Irritable Bowel Disorders
    • 9.2.5. Multiple Sclerosis
    • 9.2.6. Psoriasis
  • 9.3. Emergency Drugs
    • 9.3.1. Anaphylactic Socks
    • 9.3.2. Migraine
  • 9.4. Hormone Replacement Therapies
    • 9.4.1. Beta-Interferon
    • 9.4.2. Erythropoietin
    • 9.4.3. Follicle Stimulating Hormone
    • 9.4.4. Heparin
    • 9.4.5. Insulin
    • 9.4.6. Parathyroid Hormone
    • 9.4.7. Parkinson's

10. Americas Self-injections Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Self-injections Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Self-injections Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. New Product Launch & Enhancement
      • 13.3.1.1. DALI Medical's SAN Light Passive Safety Needle coupled with a novel Drug Product, Enabling User-friendly Administration

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. SELF-INJECTIONS MARKET RESEARCH PROCESS
  • FIGURE 2. SELF-INJECTIONS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. SELF-INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. SELF-INJECTIONS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. SELF-INJECTIONS MARKET SIZE, BY USAGE, 2022 VS 2030 (%)
  • FIGURE 6. SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • FIGURE 7. SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2022 VS 2030 (%)
  • FIGURE 8. SELF-INJECTIONS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. SELF-INJECTIONS MARKET DYNAMICS
  • FIGURE 10. SELF-INJECTIONS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. SELF-INJECTIONS MARKET SIZE, BY USAGE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. SELF-INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. SELF-INJECTIONS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. SELF-INJECTIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. SELF-INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. SELF-INJECTIONS MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. SELF-INJECTIONS MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. SELF-INJECTIONS MARKET SIZE, BY PEN INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. SELF-INJECTIONS MARKET SIZE, BY WEARABLE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 10. SELF-INJECTIONS MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. SELF-INJECTIONS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 13. SELF-INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. SELF-INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. SELF-INJECTIONS MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 18. SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. SELF-INJECTIONS MARKET SIZE, BY AIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. SELF-INJECTIONS MARKET SIZE, BY ALLERGIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. SELF-INJECTIONS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. SELF-INJECTIONS MARKET SIZE, BY IRRITABLE BOWEL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. SELF-INJECTIONS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. SELF-INJECTIONS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 26. SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. SELF-INJECTIONS MARKET SIZE, BY ANAPHYLACTIC SOCKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. SELF-INJECTIONS MARKET SIZE, BY MIGRAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 30. SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. SELF-INJECTIONS MARKET SIZE, BY BETA-INTERFERON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. SELF-INJECTIONS MARKET SIZE, BY ERYTHROPOIETIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. SELF-INJECTIONS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. SELF-INJECTIONS MARKET SIZE, BY HEPARIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. SELF-INJECTIONS MARKET SIZE, BY INSULIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. SELF-INJECTIONS MARKET SIZE, BY PARATHYROID HORMONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. SELF-INJECTIONS MARKET SIZE, BY PARKINSON'S, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 329. SELF-INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 330. SELF-INJECTIONS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 331. SELF-INJECTIONS MARKET LICENSE & PRICING